Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Enterprise Value (2020 - 2025)

Historic Enterprise Value for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to -$46.8 million.

  • MDxHealth's Enterprise Value rose 502.11% to -$46.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.8 million, marking a year-over-year increase of 502.11%. This contributed to the annual value of -$22.4 million for FY2024, which is 23351.63% down from last year.
  • Per MDxHealth's latest filing, its Enterprise Value stood at -$46.8 million for Q3 2025, which was up 502.11% from -$46.8 million recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Enterprise Value peaked at $22.5 million during Q4 2022, and registered a low of -$65.7 million during Q1 2025.
  • For the 5-year period, MDxHealth's Enterprise Value averaged around -$33.7 million, with its median value being -$43.4 million (2022).
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 121864.92% in 2021, then skyrocketed by 14666.24% in 2022.
  • Over the past 5 years, MDxHealth's Enterprise Value (Quarter) stood at -$48.2 million in 2021, then soared by 146.66% to $22.5 million in 2022, then decreased by 25.51% to $16.8 million in 2023, then plummeted by 379.19% to -$46.8 million in 2024, then changed by 0.0% to -$46.8 million in 2025.
  • Its Enterprise Value stands at -$46.8 million for Q3 2025, versus -$46.8 million for Q2 2025 and -$65.7 million for Q1 2025.